Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TL-007
- Development stage
- Preclinical
- Lead developer
- TrueLab Biopharmaceutical
- Modality
- Trispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Subcutaneous
01
Overview
TL-007 is a half-life extended (HLE) trispecific antibody currently in the discovery stage, developed by TrueLab Biopharmaceutical. It is designed for the treatment of inflammatory bowel diseases (IBD), specifically ulcerative colitis (UC) and Crohn's disease (CD). The molecule is engineered to simultaneously target three distinct pathways involved in IBD pathogenesis: tumor necrosis factor-like ligand 1A (TL1A), the p19 subunit of interleukin-23 (IL23p19), and the α4β7 integrin. By inhibiting these three targets, TL-007 aims to provide superior therapeutic efficacy compared to monotherapies by addressing multiple inflammatory and fibrotic drivers within the gut environment.
02
Targets
IL23A (Interleukin-23 p19 Subunit)α4β7 (Integrin alpha-4 beta-7 heterodimer)TL1A (TNF-like cytokine 1A)
Beyond the preview
Go deeper on TL-007.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TL-007.